347 related articles for article (PubMed ID: 22481199)
21. Cutaneous manifestations in 404 Iranian patients with inflammatory bowel disease: a retrospective study.
Moravvej H; Razavi GM; Farshchian M; Malekzadeh R
Indian J Dermatol Venereol Leprol; 2008; 74(6):607-10. PubMed ID: 19171983
[TBL] [Abstract][Full Text] [Related]
22. Mucocutaneous manifestations in inflammatory bowel disease.
Yüksel I; Başar O; Ataseven H; Ertuğrul I; Arhan M; Ibiş M; Dağli U; Demirel BT; Ulker A; Seçilmiş S; Saşmaz N
Inflamm Bowel Dis; 2009 Apr; 15(4):546-50. PubMed ID: 19023896
[TBL] [Abstract][Full Text] [Related]
23. Various skin manifestations related to inflammatory bowel disease: A nationwide cross-sectional study on the Korean population.
Jo UH; Lee JY; Lee H; Kim DY; Kang S; Koh SJ; Park H
J Dermatol; 2021 Apr; 48(4):431-438. PubMed ID: 33608949
[TBL] [Abstract][Full Text] [Related]
24. Dermatologic manifestations in pediatric patients with inflammatory bowel disease.
Afarideh M; Bartoletta K; Tollefson MM
Pediatr Dermatol; 2024; 41(2):234-242. PubMed ID: 38326222
[TBL] [Abstract][Full Text] [Related]
25. Extraintestinal Manifestations in Vedolizumab and Anti-TNF-Treated Patients With Inflammatory Bowel Disease.
Dubinsky MC; Cross RK; Sandborn WJ; Long M; Song X; Shi N; Ding Y; Eichner S; Pappalardo B; Ganguli A; Wang A
Inflamm Bowel Dis; 2018 Aug; 24(9):1876-1882. PubMed ID: 29668916
[TBL] [Abstract][Full Text] [Related]
26. The Risk of Later Diagnosis of Inflammatory Bowel Disease in Patients With Dermatological Disorders Associated With Inflammatory Bowel Disease.
King D; Chandan JS; Thomas T; Nirantharakumar K; Reulen RC; Adderley NJ; Trudgill N
Inflamm Bowel Dis; 2021 Oct; 27(11):1731-1739. PubMed ID: 34669933
[TBL] [Abstract][Full Text] [Related]
27. TRAF3IP2 gene is associated with cutaneous extraintestinal manifestations in inflammatory bowel disease.
Ciccacci C; Biancone L; Di Fusco D; Ranieri M; Condino G; Giardina E; Onali S; Lepre T; Pallone F; Novelli G; Borgiani P
J Crohns Colitis; 2013 Feb; 7(1):44-52. PubMed ID: 22445837
[TBL] [Abstract][Full Text] [Related]
28. Disease-related and drug-induced skin manifestations in inflammatory bowel disease.
Hindryckx P; Novak G; Costanzo A; Danese S
Expert Rev Gastroenterol Hepatol; 2017 Mar; 11(3):203-214. PubMed ID: 28095714
[TBL] [Abstract][Full Text] [Related]
29. [Extra intestinal manifestations of Crohn's disease (author's transl)].
Preel JL; Weissman A; Hardouin JP; Debray C
Sem Hop; 1979 Mar 18-25; 55(1112):552-9. PubMed ID: 224470
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory bowel disease in Iran: a review of 457 cases.
Aghazadeh R; Zali MR; Bahari A; Amin K; Ghahghaie F; Firouzi F
J Gastroenterol Hepatol; 2005 Nov; 20(11):1691-5. PubMed ID: 16246187
[TBL] [Abstract][Full Text] [Related]
31. [Cutaneous symptoms of ulcero-haemorragic rectocolitis and of Crohn's disease (author's transl)].
Thivolet J; Ortonne JP; Jeune R
Ann Dermatol Venereol; 1978; 105(8-9):723-7. PubMed ID: 367248
[TBL] [Abstract][Full Text] [Related]
32. Newer aspects of inflammatory bowel disease and its cutaneous manifestations: a selective review.
Apgar JT
Semin Dermatol; 1991 Sep; 10(3):138-47. PubMed ID: 1931561
[TBL] [Abstract][Full Text] [Related]
33. [Erythema nodosum and Crohn's disease].
Areias E; García E Silva L
Med Cutan Ibero Lat Am; 1984; 12(6):489-95. PubMed ID: 6152299
[TBL] [Abstract][Full Text] [Related]
34. Treatment of erythema nodosum, aphthous stomatitis, and pyoderma gangrenosum in patients with IBD.
Tremaine WJ
Inflamm Bowel Dis; 1998 Feb; 4(1):68-9; discussion 73. PubMed ID: 9552230
[No Abstract] [Full Text] [Related]
35. Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity.
Dotson JL; Hyams JS; Markowitz J; LeLeiko NS; Mack DR; Evans JS; Pfefferkorn MD; Griffiths AM; Otley AR; Bousvaros A; Kugathasan S; Rosh JR; Keljo D; Carvalho RS; Tomer G; Mamula P; Kay MH; Kerzner B; Oliva-Hemker M; Langton CR; Crandall W
J Pediatr Gastroenterol Nutr; 2010 Aug; 51(2):140-5. PubMed ID: 20453677
[TBL] [Abstract][Full Text] [Related]
36. [Inflammatory intestinal diseases and their extra-intestinal manifestations observed at Liban].
Ghayad E; Haddad F; el Aam C; Tohmé A; Nasr W
J Med Liban; 1997 Dec; 45(4):191-6. PubMed ID: 9747008
[TBL] [Abstract][Full Text] [Related]
37. [Cutaneous involvement in chronic inflammatory bowel disease : Crohn's disease and ulcerative colitis].
Richter L; Rappersberger K
Hautarzt; 2016 Dec; 67(12):940-947. PubMed ID: 27830291
[TBL] [Abstract][Full Text] [Related]
38. Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients.
Farhi D; Cosnes J; Zizi N; Chosidow O; Seksik P; Beaugerie L; Aractingi S; Khosrotehrani K
Medicine (Baltimore); 2008 Sep; 87(5):281-293. PubMed ID: 18794711
[TBL] [Abstract][Full Text] [Related]
39. Mucocutaneous manifestations of inflammatory bowel disease in central China -a single-centre study.
Kou CX; Zhang YY; Li GW; Li J; Kong QT; Chen J; Liu F; Zhang M; Wang FY; Jiang Y; Hao LY; Ren JA; Sang H
J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):e211-e212. PubMed ID: 29194792
[No Abstract] [Full Text] [Related]
40. [Skin manifestations of pediatric inflammatory bowel disease].
Martín de Carpi J; Chávez Caraza K; Vicente Villa MA; González Enseñat MA; Vilar Escrigas P; Vila Miravet V; Guallarte Alias P; Varea Calderón V
An Pediatr (Barc); 2009 Jun; 70(6):570-7. PubMed ID: 19446510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
